1038 related articles for article (PubMed ID: 28180924)
21. Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics.
Kim J; Choi SJ; Lee SH; Lee HY; Park H
AJR Am J Roentgenol; 2018 Nov; 211(5):1026-1034. PubMed ID: 30240304
[TBL] [Abstract][Full Text] [Related]
22. Radiomics-based nomogram using CT imaging for noninvasive preoperative prediction of early recurrence in patients with hepatocellular carcinoma.
Zhu HB; Zheng ZY; Zhao H; Zhang J; Zhu H; Li YH; Dong ZY; Xiao LS; Kuang JJ; Zhang XL; Liu L
Diagn Interv Radiol; 2020 Sep; 26(5):411-419. PubMed ID: 32490826
[TBL] [Abstract][Full Text] [Related]
23. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
24. Tumor and peritumor radiomics analysis based on contrast-enhanced CT for predicting early and late recurrence of hepatocellular carcinoma after liver resection.
Li N; Wan X; Zhang H; Zhang Z; Guo Y; Hong D
BMC Cancer; 2022 Jun; 22(1):664. PubMed ID: 35715783
[TBL] [Abstract][Full Text] [Related]
25. Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.
Wu M; Tan H; Gao F; Hai J; Ning P; Chen J; Zhu S; Wang M; Dou S; Shi D
Eur Radiol; 2019 Jun; 29(6):2802-2811. PubMed ID: 30406313
[TBL] [Abstract][Full Text] [Related]
26. A clinical-radiomic-pathomic model for prognosis prediction in patients with hepatocellular carcinoma after radical resection.
Xie Q; Zhao Z; Yang Y; Wang X; Wu W; Jiang H; Hao W; Peng R; Luo C
Cancer Med; 2024 Jun; 13(11):e7374. PubMed ID: 38864473
[TBL] [Abstract][Full Text] [Related]
27. Preoperative prediction for pathological grade of hepatocellular carcinoma via machine learning-based radiomics.
Mao B; Zhang L; Ning P; Ding F; Wu F; Lu G; Geng Y; Ma J
Eur Radiol; 2020 Dec; 30(12):6924-6932. PubMed ID: 32696256
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of a clinical-radiomics model to predict recurrence for patients with hepatocellular carcinoma after curative resection.
Ren Y; Bo L; Shen B; Yang J; Xu S; Shen W; Chen H; Wang X; Chen H; Cai X
Med Phys; 2023 Feb; 50(2):778-790. PubMed ID: 36269204
[TBL] [Abstract][Full Text] [Related]
29. CT radiomics nomogram for the preoperative prediction of severe post-hepatectomy liver failure in patients with huge (≥ 10 cm) hepatocellular carcinoma.
Xiang F; Liang X; Yang L; Liu X; Yan S
World J Surg Oncol; 2021 Dec; 19(1):344. PubMed ID: 34895260
[TBL] [Abstract][Full Text] [Related]
30. Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.
Huang Y; Liu Z; He L; Chen X; Pan D; Ma Z; Liang C; Tian J; Liang C
Radiology; 2016 Dec; 281(3):947-957. PubMed ID: 27347764
[TBL] [Abstract][Full Text] [Related]
31. A radiomics-based model for prediction of lymph node metastasis in gastric cancer.
Gao X; Ma T; Cui J; Zhang Y; Wang L; Li H; Ye Z
Eur J Radiol; 2020 Aug; 129():109069. PubMed ID: 32464581
[TBL] [Abstract][Full Text] [Related]
32. Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction.
Zhang Z; Jiang H; Chen J; Wei Y; Cao L; Ye Z; Li X; Ma L; Song B
Cancer Imaging; 2019 May; 19(1):22. PubMed ID: 31088553
[TBL] [Abstract][Full Text] [Related]
33. Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy.
Tang S; Ou J; Liu J; Wu YP; Wu CQ; Chen TW; Zhang XM; Li R; Tang MJ; Yang LQ; Tan BG; Lu FL; Hu J
Cancer Imaging; 2021 May; 21(1):38. PubMed ID: 34039403
[TBL] [Abstract][Full Text] [Related]
34. Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules.
Mokrane FZ; Lu L; Vavasseur A; Otal P; Peron JM; Luk L; Yang H; Ammari S; Saenger Y; Rousseau H; Zhao B; Schwartz LH; Dercle L
Eur Radiol; 2020 Jan; 30(1):558-570. PubMed ID: 31444598
[TBL] [Abstract][Full Text] [Related]
35. CT-Based Radiomics Nomogram: A Potential Tool for Differentiating Hepatocellular Adenoma From Hepatocellular Carcinoma in the Noncirrhotic Liver.
Nie P; Wang N; Pang J; Yang G; Duan S; Chen J; Xu W
Acad Radiol; 2021 Jun; 28(6):799-807. PubMed ID: 32386828
[TBL] [Abstract][Full Text] [Related]
36. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.
Niu XK; He XF
World J Gastroenterol; 2021 Jan; 27(2):189-207. PubMed ID: 33510559
[TBL] [Abstract][Full Text] [Related]
37. Radiomics Analysis Based on Multiparametric MRI for Predicting Early Recurrence in Hepatocellular Carcinoma After Partial Hepatectomy.
Zhao Y; Wu J; Zhang Q; Hua Z; Qi W; Wang N; Lin T; Sheng L; Cui D; Liu J; Song Q; Li X; Wu T; Guo Y; Cui J; Liu A
J Magn Reson Imaging; 2021 Apr; 53(4):1066-1079. PubMed ID: 33217114
[TBL] [Abstract][Full Text] [Related]
38. Magnetic resonance radiomics signatures for predicting poorly differentiated hepatocellular carcinoma: A SQUIRE-compliant study.
Yang X; Yuan C; Zhang Y; Wang Z
Medicine (Baltimore); 2021 May; 100(19):e25838. PubMed ID: 34106622
[TBL] [Abstract][Full Text] [Related]
39. Radiomics model of contrast-enhanced computed tomography for predicting the recurrence of acute pancreatitis.
Chen Y; Chen TW; Wu CQ; Lin Q; Hu R; Xie CL; Zuo HD; Wu JL; Mu QW; Fu QS; Yang GQ; Zhang XM
Eur Radiol; 2019 Aug; 29(8):4408-4417. PubMed ID: 30413966
[TBL] [Abstract][Full Text] [Related]
40. Deep Learning-Based Radiomics Models for Early Recurrence Prediction of Hepatocellular Carcinoma with Multi-phase CT Images and Clinical Data.
Wang W; Chen Q; Iwamoto Y; Han X; Zhang Q; Hu H; Lin L; Chen YW
Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():4881-4884. PubMed ID: 31946954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
